Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Operating Leases (2021 - 2025)

Historic Operating Leases for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2025 value amounting to $2.0 million.

  • Burning Rock Biotech's Operating Leases fell 8032.66% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 8032.66%. This contributed to the annual value of $7.2 million for FY2024, which is 31290.32% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Operating Leases of $2.0 million as of Q3 2025, which was down 8032.66% from $2.5 million recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Operating Leases high stood at $29.7 million for Q4 2021, and its period low was $700000.0 during Q3 2023.
  • Moreover, its 5-year median value for Operating Leases was $2.7 million (2022), whereas its average is $5.7 million.
  • Per our database at Business Quant, Burning Rock Biotech's Operating Leases surged by 138714.29% in 2024 and then plummeted by 8032.66% in 2025.
  • Over the past 5 years, Burning Rock Biotech's Operating Leases (Quarter) stood at $29.7 million in 2021, then tumbled by 75.18% to $7.4 million in 2022, then crashed by 76.43% to $1.7 million in 2023, then surged by 312.9% to $7.2 million in 2024, then crashed by 71.43% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.5 million for Q2 2025, and $2.7 million during Q1 2025.